News
-
Perivan clients are winners in 4 different AIC categories
September 2023
-
Scheme document published for the £3.11 million recommended cash acquisition of Osirium Technologies by Sailpoint Technologies
September 2023
-
Perivan produce Direct Mail Campaign for World Cancer Research Fund
September 2023
-
Tribe Technology float on AIM
September 2023
-
Nippon Active Value Fund publish Scheme of Reconstruction prospectus
September 2023
-
Perivan welcomes Quiz to our Annual Report portfolio
August 2023
-
Perivan welcomes Recognise Bank to our Annual Report portfolio
August 2023
-
Tan Delta Systems float on AIM
August 2023
-
Aptamer Group launches a £3.6 million fundraising
August 2023
-
Eden Research launches fundraise for up to £11 million to fund materials to build up stocks for its new seed treatment
August 2023
-
Scheme document published for the £16.7 million recommended cash acquisition of Yourgene Health by Novacyt Copy
July 2023
-
Bivictrix Therapeutics raises £2.1 million via a Placing and Subscription
July 2023
-
Perivan attend the London Stock Exchange Marketplace Summer Networking Drinks
July 2023
-
Perivan's Annual Report client portfolio has surpassed 300
July 2023
-
Deltex completes £1.7 million fundraise and launches retail offer
July 2023
-
Perivan to exhibit at Sifted Summit 2023
July 2023
